Clincosm LogoSign in Get a demo

severe hypertriglyceridemia

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Hypertriglyceridemia Trial (Pegozafermin, Placebo)

Not yet recruiting
  • Severe Hypertriglyceridemia
  • (no location specified)
May 2, 2023

Severe Hypertriglyceridemia Trial in Canada, United States (Olezarsen, Placebo)

Recruiting
  • Severe Hypertriglyceridemia
  • Birmingham, Alabama
  • +24 more
Jan 25, 2023

Severe Hypertriglyceridemia Trial in Worldwide (Olezarsen, Placebo)

Recruiting
  • Severe Hypertriglyceridemia
  • Chula Vista, California
  • +109 more
Jan 23, 2023

Severe Hypertriglyceridemia Trial in Boca Raton, Rapid City, Manassas (Olezarsen)

Recruiting
  • Severe Hypertriglyceridemia
  • Boca Raton, Florida
  • +2 more
Jan 12, 2023

Severe Hypertriglyceridemia Trial in Worldwide (ARO-APOC3, Placebo)

Active, not recruiting
  • Severe Hypertriglyceridemia
  • Beverly Hills, California
  • +72 more
Nov 29, 2022

Severe Hypertriglyceridemia Trial in Worldwide (K-877, Fenofibrate, Placebo (for K-877))

Completed
Has Results
  • Severe Hypertriglyceridemia
  • Birmingham, Alabama
  • +219 more
Nov 9, 2022

Hypertriglyceridemia, Atherosclerotic Cardiovascular Disease, Severe Hypertriglyceridemia Trial in Canada, United States

Active, not recruiting
  • Hypertriglyceridemia
  • +2 more
  • Lincoln, California
  • +23 more
Nov 23, 2022

Severe Hypertriglyceridemia Trial in Worldwide (K-877, Fenofibrate, Placebo (for K-877))

Completed
Has Results
  • Severe Hypertriglyceridemia
  • Birmingham, Alabama
  • +240 more
Sep 30, 2022

Severe Hypertriglyceridemia Trial in Worldwide (BIO89-100, Placebo)

Completed
  • Severe Hypertriglyceridemia
  • La Mesa, California
  • +47 more
Jul 26, 2022

Severe Hypertriglyceridemia Trial (Placebo, MAT9001 (omega-3 pentaenoic acid))

Withdrawn
  • Severe Hypertriglyceridemia
  • Placebo
  • MAT9001 (omega-3 pentaenoic acid)
  • (no location specified)
Sep 9, 2021

Severe Hypertriglyceridemia, Mixed Dyslipidaemia Trial in Canada, United States (Gemcabene, Placebo)

Completed
Has Results
  • Severe Hypertriglyceridemia
  • Mixed Dyslipidaemia
  • Fort Payne, Alabama
  • +48 more
Jun 3, 2020

Severe Hypertriglyceridemia Trial (Placebo, SC401B 2 capsules, SC401B 4 capsules)

Withdrawn
  • Severe Hypertriglyceridemia
  • Placebo
  • +3 more
  • (no location specified)
Nov 22, 2016

Severe Hypertriglyceridemia Trial in Worldwide (, omefas)

Completed
Has Results
  • Severe Hypertriglyceridemia
  • National City, California
  • +67 more
Jun 24, 2016

Severe Hypertriglyceridemia Trial in Canada, United States (Epanova, Lovaza)

Completed
Has Results
  • Severe Hypertriglyceridemia
  • Kansas City, Kansas
  • +3 more
May 11, 2016

Severe Hypertriglyceridemia Trial in Chicago (Epanova (4 g) and Lovaza (4 g), Lovaza (4 g) and Epanova (4 g))

Completed
Has Results
  • Severe Hypertriglyceridemia
  • Epanova (4 g) and Lovaza (4 g)
  • Lovaza (4 g) and Epanova (4 g)
  • Chicago, Illinois
    Radiant Research
Jun 19, 2015

Severe Hypertriglyceridemia Trial in Chicago (AKR-963)

Unknown status
  • Severe Hypertriglyceridemia
  • Chicago, Illinois
    Illinois Recruiting
Nov 23, 2011